Intranasal corticosteroids mitigate loss of smell in chronic rhinosinusitis with COVID-19
Doctors should consider intranasal corticosteroids for patients with chronic rhinosinusitis who also have COVID-19 to minimize loss of olfactory function, according to a study published in Allergy and Asthma Proceedings.This use of intranasal corticosteroids (INCs) does not aggravate the clinical course of COVID-19, Can Tuzer, MD, of the department of internal medicine’s division of
Source: healio.com